scispace - formally typeset
J

Jerzy Sadowski

Researcher at Jagiellonian University Medical College

Publications -  286
Citations -  9986

Jerzy Sadowski is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Aortic valve replacement & Aortic valve. The author has an hindex of 31, co-authored 280 publications receiving 9235 citations. Previous affiliations of Jerzy Sadowski include University of Maryland, Baltimore & University of Oxford.

Papers
More filters
Journal ArticleDOI

Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine.

TL;DR: Evaluating fibrin clot properties in middle-aged and elderly patients with advanced CAD studied 133 patients with angiographically proven CAD, who qualified for elective coronary artery bypass grafting surgery.
Journal ArticleDOI

Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans.

TL;DR: Denser fibrin clots with reduced susceptibility to lysis might characterize the progression of both diseases during long-term follow-up and test the hypothesis that PAD and TAO are associated with prothrombotic phenotype of a fibrIn clot.
Journal Article

Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results.

TL;DR: As surgical and device closure appear similarly effective in adults with ASD, avoidance of thoracotomy and cardiopulmonary bypass, in conjunction with a shorter hospital stay, argues in favour of device closure in selected patients.
Journal ArticleDOI

CD14 + CD16 ++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease

TL;DR: The data indicate that CD14+CD16++ "nonclassical" monocytes are associated with more advanced vascular dysfunction measured as NO- bioavailability and vascular reactive oxygen species production.